Press Releases Brain+ A/S

Equities

BRAINP

DK0061670205

Market Closed - Nasdaq Copenhagen Other stock markets 09:58:34 2024-05-16 EDT			5-day change	1st Jan Change
0.1 ^DKK	-2.44%		+7.53%	-48.45%

05-07	Brain+ Plans DKK9 Million Rights Issue to Help Fund Operations	MT
05-07	Brain+ A/S Provides Earnings Guidance for the Year 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brain+ informs of progress on its UK focused proof-of-business strategy plan	05-16	AQ
Brain+ A/S convenes the Annual General Meeting	05-07	AQ
Brain+ publishes its Annual Report for 2023 - A year of market access, product development and a refocused commercial strategy	05-07	AQ
Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan	05-07	AQ
Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark	05-02	AQ
Brain+' CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia	04-30	AQ
Brain+ releases preliminary annual financial statements for 2023	04-30	AQ
Brain+ announces a change in its Financial Calendar for 2024	04-29	AQ
Successful educational CST course held with Malteser Germany based on the CST-Assistant	04-26	AQ
Brain+ announces registration of directed issue with the Danish Business Authority	04-11	AQ
Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority	04-10	AQ
Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments	03-26	AQ
Brain+ A/S specifies how to get TO 3 warrant compensation	03-26	AQ
Brain+ A/S announces last day of trading in its warrants of series TO 3	03-20	AQ
Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK	03-19	AQ
Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025	03-18	AQ
Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments	03-15	AQ
Brain+ announces that 58% of its warrants of series TO 3 are covered by early commitments	03-11	AQ
Brain+ A/S announces amended terms for upcoming TO 3 warrant exercise	03-07	AQ
Brain+ nominates an international digital health industry expert and experienced investor profile as new chairman candidate	02-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Brain+ A/S

Equities

BRAINP

DK0061670205

Press Releases

Filters